Mutations in G6PT prevent glucose-6-phosphate uptake into the ER, are associated with apoptosis and neutropenia in patients, and can be mimicked by treating wild-type cells with the G6PT inhibitor chlorogenic acid (60). Here, SLC37A4 is linked to Decreased total neutrophil count.